logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Ocular Hypertension

    FiltersReset Filters
    26 results

    • azopt

      (brinzolamide)
      Sandoz Inc
      Usage: AZOPT is indicated for treating elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma as a carbonic anhydrase inhibitor.

    • betoptic s

      (betaxolol hydrochloride)
      Novartis Pharmaceuticals Corporation
      Usage: BETOPTIC S (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Somerset Therapeutics, LLC
      Usage: Bimatoprost ophthalmic solution 0.03% is indicated for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • bimatoprost

      (Bimatoprost)
      Fosun Pharma USA Inc.
      Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • brimonidine

      (brimonidine tartrate)
      Sandoz Inc
      Usage: Brimonidine tartrate ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • brimonidine tartrate

      (Brimonidine Tartrate)
      Alembic Pharmaceuticals Inc.
      Usage: Brimonidine tartrate ophthalmic solution, 0.1% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • brimonidine tartrate and timolol maleate

      (BRIMONIDINE TARTRATE, TIMOLOL MALEATE)
      Pacific Pharma, Inc.
      Usage: Brimonidine tartrate and timolol maleate ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with glaucoma or ocular hypertension. It serves as adjunctive or replacement therapy when IOP is inadequately controlled, providing slightly less IOP-lowering efficacy than separate administration of its components.

    • brinzolamide

      (brinzolamide)
      Padagis US LLC
      Usage: Brinzolamide ophthalmic suspension is indicated for lowering elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.

    • combigan

      (brimonidine tartrate, timolol maleate)
      Allergan, Inc.
      Usage: COMBIGAN (brimonidine tartrate/timolol maleate) is indicated for reducing elevated intraocular pressure in patients with glaucoma or ocular hypertension. It serves as adjunctive or replacement therapy for those with inadequately controlled IOP, dosed twice daily for optimal effectiveness.

    • cosopt pf

      (dorzolamide hydrochloride and timolol maleate)
      Thea Pharma Inc.
      Usage: COSOPT® PF is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who do not adequately respond to beta-blockers. It is typically administered twice daily and offers a different IOP-lowering effect compared to standard therapies.